Streetbeat News

Stock Prices

SPT

Sprout Social shares are trading lower after the company announced that there is no process in place to sell or take the company private.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:34 pm

ODD

ODDITY Tech shares are trading lower following a report from NINGI Research, which announced a short position on the company.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:34 pm

SPT

Sprout Social has announced that there is no current process in place to sell or take the company private.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:34 pm

TSLA

Morgan Stanley analyst Adam Jonas emphasizes the critical role of Tesla Inc (NASDAQ:TSLA) in Elon Musk's AI ambitions. Jonas believes Tesla's success in AI will lower capital costs for Musk's other ventures, while failure will increase costs. The upcoming shareholder vote on Musk's 2018 pay package and the potential shift of Tesla's incorporation from Delaware to Texas could drive significant stock volatility.

Portfolio Pulse from Anan Ashraf

May 21, 2024 | 12:33 pm

CVNA

GS

NRDY

YUM

The Nasdaq 100 closed higher by over 100 points on Monday. Notable insider trades were observed in Nerdy, Carvana, Goldman Sachs, and Yum! Brands. Insider sales can indicate various factors, including concerns about company prospects or stock overvaluation.

Portfolio Pulse from Avi Kapoor

May 21, 2024 | 12:30 pm

GLBE

Global-E Online Ltd. (NASDAQ:GLBE) reported better-than-expected Q1 FY24 sales results, raised its FY24 revenue guidance, and saw analysts increase their price targets. The company reported a 24% YoY sales growth to $145.90 million, beating the consensus estimate of $141.5 million. Loss per share was 19 cents, better than the expected 23 cents. The company raised its FY24 sales guidance to $733 million – $773 million and sees FY24 GMV of $4.625 billion – $4.865 billion. Analysts from Morgan Stanley, B of A Securities, and Needham increased their price targets and ratings for GLBE.

Portfolio Pulse from Avi Kapoor

May 21, 2024 | 12:30 pm

VIR

Vir Biotechnology's SOLSTICE data will be featured as an oral presentation at the EASL Congress 2024. The company will present new data on the efficacy and safety of tobevibart and elebsiran for chronic hepatitis delta treatment.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:30 pm

ONVO

Organovo Holdings, Inc. (NASDAQ:ONVO) presented data at Digestive Disease Week (DDW2024) showing the potential of its lead compound, FXR314, in combination with tofacitinib for treating inflammatory bowel disease (IBD). The data was derived from 3D and preclinical models.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:28 pm

ARDX

Ardelyx, Inc. (NASDAQ:ARDX) presented additional positive clinical data on IBSRELA, a first-in-class treatment for IBS-C in adults, at the 2024 Digestive Disease Week Conference.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:27 pm

MRNA

MSFT

SNY

Sanofi SA has announced a collaboration with OpenAI and Formation Bio to accelerate AI-driven drug development. This partnership will combine data, software, and AI models to create custom solutions for the drug development lifecycle. OpenAI will provide AI capabilities and expertise, while Formation Bio will contribute engineering resources and its tech-driven development platform. This collaboration aims to set a new standard in drug development. Additionally, Moderna and Microsoft-backed OpenAI have an ongoing collaboration to co-innovate, with Moderna achieving significant internal adoption of its AI tool, mChat.

Portfolio Pulse from Vandana Singh

May 21, 2024 | 12:24 pm